Beschreibung
Supplementary information from the review of regenerative cellular therapies for non-scarring alopecia.
Cite This Figure
![Figure 5: Supplementary information from the review of regenerative cellular therapies for non-scarring alopecia.]() > Source: Talagavadi Channaiah Anudeep et al. "Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.." *Pharmaceutics*, 2022. PMID: [35335987](https://pubmed.ncbi.nlm.nih.gov/35335987/)
<figure> <img src="" alt="Supplementary information from the review of regenerative cellular therapies for non-scarring alopecia." /> <figcaption>Figure 5. Supplementary information from the review of regenerative cellular therapies for non-scarring alopecia.<br> Source: Talagavadi Channaiah Anudeep et al. "Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia.." <em>Pharmaceutics</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35335987/">35335987</a></figcaption> </figure>
Verwandte Evidenz
A
Minoxidil für Androgenetische Alopezie
A
Bewertung A · 299 Studien
Finasterid für Androgenetische Alopezie
A
Bewertung A · 206 Studien
PRP-Therapie für Alopecia Areata
A
Bewertung A · 89 Studien
Minoxidil für Alopecia Areata
A
Bewertung A · 122 Studien
PRP-Therapie für Androgenetische Alopezie
Bewertung A · 144 Studien